Addex Therapeutics(ADXN) - 2024 Q2 - Earnings Call Transcript

Addex Therapeutics Ltd (NASDAQ:ADXN) Q2 2024 Earnings Conference Call September 30, 2024 10:00 AM ET Company Participants Tim Dyer - Co-Founder, Board Director and Chief Executive Officer Misha Kalinichev - Head, Translational Science Conference Call Participants Raghuram Selvaraju - H.C. Wainwright & Co. Operator Good day, and thank you for standing by. Welcome to the Addex Therapeutics Half-Year 2024 Financial Results and Corporate Update Conference Call. At this time, all participants are in listen-only ...